Skip to main content

SB 504 (2026)

Revise pharmacy practice laws and dispensing authority, authorize experimental treatment centers, expand Right to Try

This bill did not become law.

Last updated 2026-06-19 8:38 pm
Summary:

Modifies pharmacy regulations to allow healthcare providers to dispense up to a 30-day supply of oral anti-cancer medication and authorizes advanced pharmacy technicians to perform remote processing. It also updates license display requirements, removes the requirement for a pharmacist's name on prescription labels, and redefines the "practice of pharmacy."

The Senate amended the bill to change many other laws related to pharmacists. For example, the amended bill prohibits the pharmacy board from testing applicants on pharmacy jurisprudence or law.

The House amended the bill to add the substance of HB 1734 (authorizing experimental treatment centers) and HB 1735 (expanding Right to Try to severe illnesses).

The Senate then added their version of the bill to HB 194.

Bill Sponsor:
David Rochefort
Republican party logo
Status:
SENATE
Status Detail:
Killed in the Senate
Public Hearing Date:
04/15/2026 01:10 pm
Public Hearing Location:
GP Room 231
House Voting Date:
05/14/2026
Senate Voting Date:
03/26/2026
Browse related articles and bills:
Thank you to our sponsors and donors